Cargando…
Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer’s Coordinating Center Uniform Data Set
BACKGROUND: Evidence on the relative risk of death across all stages of Alzheimer’s disease (AD) is lacking but greatly needed for the evaluation of new interventions. We used data from the Uniform Data Set (UDS) of the National Alzheimer’s Coordinating Center (NACC) to assess the expected survival...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424331/ https://www.ncbi.nlm.nih.gov/pubmed/37580727 http://dx.doi.org/10.1186/s12883-023-03353-w |
_version_ | 1785089647291924480 |
---|---|
author | Crowell, Valerie Reyes, Adriana Zhou, Summera Qiheng Vassilaki, Maria Gsteiger, Sandro Gustavsson, Anders |
author_facet | Crowell, Valerie Reyes, Adriana Zhou, Summera Qiheng Vassilaki, Maria Gsteiger, Sandro Gustavsson, Anders |
author_sort | Crowell, Valerie |
collection | PubMed |
description | BACKGROUND: Evidence on the relative risk of death across all stages of Alzheimer’s disease (AD) is lacking but greatly needed for the evaluation of new interventions. We used data from the Uniform Data Set (UDS) of the National Alzheimer’s Coordinating Center (NACC) to assess the expected survival of a person progressing to a particular stage of AD and the relative risk of death for a person in a particular stage of AD compared with cognitively normal (CN) people. METHODS: This was a retrospective observational cohort study of mortality and its determinants in participants with incident mild cognitive impairment (MCI) due to AD or AD dementia compared with CN participants. Overall survival and hazard ratios of all-cause mortality in participants ≥ 50 years of age with clinically assessed or diagnosed MCI due to AD, or mild, moderate, or severe AD dementia, confirmed by Clinical Dementia Rating scores, versus CN participants were estimated, using NACC UDS data. Participants were followed until death, censoring, or until information to determine disease stage was missing. RESULTS: Aged between 50 and 104 years, 12,414 participants met the eligibility criteria for the study. Participants progressing to MCI due to AD or AD dementia survived a median of 3–12 years, with higher mortality observed in more severe stages. Risk of death increased with the severity of AD dementia, with the increase significantly higher at younger ages. Participants with MCI due to AD and CN participants had a similar risk of death after controlling for confounding factors. CONCLUSIONS: Relative all-cause mortality risk increases with AD severity, more so at younger ages. Mortality does not seem to be higher for those remaining in MCI due to AD. Findings might imply potential benefit of lower mortality if preventing or delaying the progression of AD is successful, and importantly, this potential benefit might be greater in relatively younger people. Future research should replicate our study in other samples more representative of the general US population as well as other populations around the world. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12883-023-03353-w. |
format | Online Article Text |
id | pubmed-10424331 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104243312023-08-15 Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer’s Coordinating Center Uniform Data Set Crowell, Valerie Reyes, Adriana Zhou, Summera Qiheng Vassilaki, Maria Gsteiger, Sandro Gustavsson, Anders BMC Neurol Research BACKGROUND: Evidence on the relative risk of death across all stages of Alzheimer’s disease (AD) is lacking but greatly needed for the evaluation of new interventions. We used data from the Uniform Data Set (UDS) of the National Alzheimer’s Coordinating Center (NACC) to assess the expected survival of a person progressing to a particular stage of AD and the relative risk of death for a person in a particular stage of AD compared with cognitively normal (CN) people. METHODS: This was a retrospective observational cohort study of mortality and its determinants in participants with incident mild cognitive impairment (MCI) due to AD or AD dementia compared with CN participants. Overall survival and hazard ratios of all-cause mortality in participants ≥ 50 years of age with clinically assessed or diagnosed MCI due to AD, or mild, moderate, or severe AD dementia, confirmed by Clinical Dementia Rating scores, versus CN participants were estimated, using NACC UDS data. Participants were followed until death, censoring, or until information to determine disease stage was missing. RESULTS: Aged between 50 and 104 years, 12,414 participants met the eligibility criteria for the study. Participants progressing to MCI due to AD or AD dementia survived a median of 3–12 years, with higher mortality observed in more severe stages. Risk of death increased with the severity of AD dementia, with the increase significantly higher at younger ages. Participants with MCI due to AD and CN participants had a similar risk of death after controlling for confounding factors. CONCLUSIONS: Relative all-cause mortality risk increases with AD severity, more so at younger ages. Mortality does not seem to be higher for those remaining in MCI due to AD. Findings might imply potential benefit of lower mortality if preventing or delaying the progression of AD is successful, and importantly, this potential benefit might be greater in relatively younger people. Future research should replicate our study in other samples more representative of the general US population as well as other populations around the world. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12883-023-03353-w. BioMed Central 2023-08-14 /pmc/articles/PMC10424331/ /pubmed/37580727 http://dx.doi.org/10.1186/s12883-023-03353-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Crowell, Valerie Reyes, Adriana Zhou, Summera Qiheng Vassilaki, Maria Gsteiger, Sandro Gustavsson, Anders Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer’s Coordinating Center Uniform Data Set |
title | Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer’s Coordinating Center Uniform Data Set |
title_full | Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer’s Coordinating Center Uniform Data Set |
title_fullStr | Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer’s Coordinating Center Uniform Data Set |
title_full_unstemmed | Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer’s Coordinating Center Uniform Data Set |
title_short | Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer’s Coordinating Center Uniform Data Set |
title_sort | disease severity and mortality in alzheimer's disease: an analysis using the u.s. national alzheimer’s coordinating center uniform data set |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424331/ https://www.ncbi.nlm.nih.gov/pubmed/37580727 http://dx.doi.org/10.1186/s12883-023-03353-w |
work_keys_str_mv | AT crowellvalerie diseaseseverityandmortalityinalzheimersdiseaseananalysisusingtheusnationalalzheimerscoordinatingcenteruniformdataset AT reyesadriana diseaseseverityandmortalityinalzheimersdiseaseananalysisusingtheusnationalalzheimerscoordinatingcenteruniformdataset AT zhousummeraqiheng diseaseseverityandmortalityinalzheimersdiseaseananalysisusingtheusnationalalzheimerscoordinatingcenteruniformdataset AT vassilakimaria diseaseseverityandmortalityinalzheimersdiseaseananalysisusingtheusnationalalzheimerscoordinatingcenteruniformdataset AT gsteigersandro diseaseseverityandmortalityinalzheimersdiseaseananalysisusingtheusnationalalzheimerscoordinatingcenteruniformdataset AT gustavssonanders diseaseseverityandmortalityinalzheimersdiseaseananalysisusingtheusnationalalzheimerscoordinatingcenteruniformdataset |